Who Paid My Doc
Mti-117
ClinicalTrials.gov NCT03841331
Research payments
$370,845
Through program year 2020, $370,845 in research payments was reported against Mti-117, across 40 payments, paid by VYNE Pharmaceuticals Inc..
- Paid by
- VYNE Pharmaceuticals Inc.
- ClinicalTrials.gov
- NCT03841331
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $370,845 | 40 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Leslie Baumann Miami, FL Named on 3 payments
- Brian Kim St. Louis, MO Named on 3 payments
- Sanchayita Tripathy Rolla, MO Named on 2 payments
- Blakely Richardson Austin, TX Named on 2 payments
- William Lumry Dallas, TX Named on 2 payments
- Hugh Windom Sarasota, FL Named on 2 payments
- William Werschler Spokane, WA Named on 2 payments
- Steven Davis San Antonio, TX Named on 2 payments
- Barry Kuttner West Palm Beach, FL Named on 2 payments
- Mark Amster Brighton, MA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.